Daiichi Sankyo is headquartered in Tokyo, Japan.
Daiichi Sankyo disclosed revenue of 1,886,256M JPY for 2025 and 1,601,688M JPY for 2024.
Daiichi Sankyo has 19,765 employees.
Daiichi Sankyo is a life science company.
Daiichi Sankyo was founded in 1899.
3-5-1 Nihonbashi-Honcho Chuo-ku,
Tokyo,
103-8426
Japan,
+81 3 6225 1111
www.daiichisankyo.com
Daiichi Sankyo manufactures pharmaceuticals for human/veterinary use and medical tools and equipment. It also researches and promotes products through related companies throughout the world. The Group also produces food, food additives, livestock feeds, and agrochemicals. Daiichi Sankyo was founded in 1899 and is based in Tokyo, Japan.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 4 | - | - | - | - | - | 4 |
| vol | $6.8B | $6.8B | ||||||
| Sell (0.2/yr) | # | 3 | - | 1 | - | - | - | 4 |
| vol | $4.0B | $4.0B | ||||||
| 8 | ||||||||
| Financial | Deals |
|---|---|
|
Goldman Sachs |
1 |
| Legal | Deals |
|---|---|
|
Simpson Thacher & Bartlett |
1 |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
